Bank of America
CRBU icon

Bank of America’s Caribou Biosciences CRBU Stock Holding History

Bank of America’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.46M Buy
1,297,167
+303,981
+31% +$522K ﹤0.01% 3972
2025
Q4 		$1.58M Sell
993,186
-81,256
-8% -$171K ﹤0.01% 4251
2025
Q3 		$2.5M Buy
1,074,442
+265,542
+33% +$501K ﹤0.01% 4626
2025
Q2 		$1.02M Sell
808,900
-291,565
-26% -$287K ﹤0.01% 5288
2025
Q1 		$1M Sell
1,100,465
-668,828
-38% -$869K ﹤0.01% 5213
2024
Q4 		$2.81M Sell
1,769,293
-2,800,953
-61% -$5.63M ﹤0.01% 4147
2024
Q3 		$8.96M Buy
4,570,246
+407,899
+10% +$835K ﹤0.01% 3179
2024
Q2 		$6.83M Buy
4,162,347
+3,045,578
+273% +$9.73M ﹤0.01% 3321
2024
Q1 		$5.74M Sell
1,116,769
-476,367
-30% -$2.94M ﹤0.01% 3480
2023
Q4 		$9.13M Sell
1,593,136
-713,662
-31% -$3.53M ﹤0.01% 2991
2023
Q3 		$11M Sell
2,306,798
-444,692
-16% -$2.76M ﹤0.01% 2627
2023
Q2 		$11.7M Buy
2,751,490
+119,105
+5% +$535K ﹤0.01% 2556
2023
Q1 		$14M Buy
2,632,385
+788,483
+43% +$4.91M ﹤0.01% 2493
2022
Q4 		$11.6M Buy
1,843,902
+1,668,395
+951% +$14.8M ﹤0.01% 2540
2022
Q3 		$1.85M Buy
175,507
+102,361
+140% +$954K ﹤0.01% 4353
2022
Q2 		$397K Buy
73,146
+53,570
+274% +$410K ﹤0.01% 5596
2022
Q1 		$180K Sell
19,576
-70,566
-78% -$743K ﹤0.01% 6533
2021
Q4 		$1.36M Buy
90,142
+55,767
+162% +$1.08M ﹤0.01% 4952
2021
Q3 		$821K Buy
+34,375
New +$840K ﹤0.01% 5248

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America's CRBU Position: Q1 2026 in Review

Bank of America increased its Caribou Biosciences (CRBU) stake by 31% in Q1 2026, buying an estimated $522K and bringing the position to 1,297,167 shares worth $2.46M. The position accounts for ﹤0.01% of the portfolio, ranked #3972.

Bank of America first reported a position in CRBU in Q3 2021 and has held it in 19 quarters since. The position peaked at $14M in Q1 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Bank of America held 1,297,167 shares of Caribou Biosciences worth $2.46M as of Q1 2026.
  • Bank of America bought 303,981 Caribou Biosciences shares in Q1 2026, an estimated $522K.
  • Caribou Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3972 holding.
  • Bank of America first reported a position in Caribou Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Bank of America's Caribou Biosciences position peaked at $14M in Q1 2023.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.